South Korea Immunosuppressant Drugs Market, 2020-2027
The immunosuppressant drugs market in South Korea is expected to reach a projected revenue of US$ 3,397.7 million by 2027. A compound annual growth rate of 8.4% is expected of South Korea immunosuppressant drugs market from 2021 to 2027.
South Korea immunosuppressant drugs market highlights
The South Korea immunosuppressant drugs market generated a revenue of USD 1,927.6 million in 2020 and is expected to reach USD 3,397.7 million by 2027.
The South Korea market is expected to grow at a CAGR of 8.4% from 2021 to 2027.
In terms of segment, monoclonal antibodies was the largest revenue generating drug class in 2020.
Monoclonal Antibodies is the most lucrative drug class segment registering the fastest growth during the forecast period.
In terms of revenue, South Korea accounted for 2.0% of the global immunosuppressant drugs market in 2020.
Country-wise, U.S. is expected to lead the global market in terms of revenue in 2027.
In Asia Pacific, China immunosuppressant drugs market is projected to lead the regional market in terms of revenue in 2027.
China is the fastest growing regional market in Asia Pacific and is projected to reach USD 9,785.3 million by 2027.
Dental caries and periodontal disease constitute substantial dental disease burden in South Korean. According to a survey published by PubMed in 2019, dental caries and PD increased by 39.2% and 57.0%, respectively, between 2013 and 2015 and were leading cause of disability adjusted life years (DALYs).
According to BMC Oral Health in 2017, 43.9% Of South Korean adults perceived unmet dental needs with the most common reason being financial difficulties and is majorly associated with income level, normative treatment needs, and self-perceived oral health status.
The aged population is also rapidly increasing in South Korea, and a total of 96.4% experienced dental caries among them. The country largely benefits from the primary and secondary dental care by National Health Insurance and the cost for the dental treatment is covered except for prosthetic and esthetic dental care.
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to Immunosuppressant Drugs Market will help companies and investors design strategic landscapes.
Monoclonal Antibodies was the largest segment with a revenue share of 72.86% in 2020.
Horizon Databook has segmented the South Korea immunosuppressant drugs market based on calcineurin inhibitors, mtor inhibitors, antiproliferative agents, monoclonal antibodies covering the revenue growth of each sub-segment from 2016 to 2027.
Dental caries and periodontal disease constitute substantial dental disease burden in South Korean. According to a survey published by PubMed in 2019, dental caries and PD increased by 39.2% and 57.0%, respectively, between 2013 and 2015 and were leading cause of disability adjusted life years (DALYs).
According to BMC Oral Health in 2017, 43.9% Of South Korean adults perceived unmet dental needs with the most common reason being financial difficulties and is majorly associated with income level, normative treatment needs, and self-perceived oral health status.
The aged population is also rapidly increasing in South Korea, and a total of 96.4% experienced dental caries among them. The country largely benefits from the primary and secondary dental care by National Health Insurance and the cost for the dental treatment is covered except for prosthetic and esthetic dental care.
South Korea Immunosuppressant Drugs Market Drug Class Outlook (Revenue, USD Million , 2016-2027)
Calcineurin Inhibitors
mTOR Inhibitors
Antiproliferative Agents
Monoclonal Antibodies
Others
South Korea Immunosuppressant Drugs Market Application Outlook (Revenue, USD Million , 2016-2027)
Autoimmune Diseases
Organ Transplants
Other Applications
South Korea Immunosuppressant Drugs Market Route of Administration Outlook (Revenue, USD Million , 2016-2027)
Oral
Injectables
South Korea Immunosuppressant Drugs Market Distribution Channel Outlook (Revenue, USD Million , 2016-2027)
Hospital Pharmacy
Retail Pharmacy
Online Pharmacy
Reasons to subscribe to Immunosuppressant Drugs Market databook
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Immunosuppressant Drugs Market databook
Our clientele includes a mix of Immunosuppressant Drugs Market companies, investment firms, advisory firms & academic institutions.
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of country-level data and insights on the South Korea Immunosuppressant Drugs Market, including forecasts for subscribers. This country databook contains high-level insights into South Korea Immunosuppressant Drugs Market from 2016 to 2027, including revenue numbers, major trends, and company profiles.
South Korea Immunosuppressant Drugs Market, 2016-2027 (US$M)